ChemicalBook >> CAS DataBase List >>ROTIGOTINE

ROTIGOTINE

CAS No.
99755-59-6
Chemical Name:
ROTIGOTINE
Synonyms
Neupro;N 0923;CS-110;SPM 962;Rotigotine;S(-)-N-0437;14C]-Rotigotine;Rotigotine (Base);Rotigotine (N-0437;ROTIGOTINE USP/EP/BP
CBNumber:
CB81001679
Molecular Formula:
C19H25NOS
Molecular Weight:
315.47
MDL Number:
MFCD00870193
MOL File:
99755-59-6.mol
MSDS File:
SDS
Last updated:2023-07-20 14:19:32

ROTIGOTINE Properties

Melting point 78 °C
Boiling point 470.1±45.0 °C(Predicted)
Density 1.15±0.1 g/cm3(Predicted)
storage temp. room temp
Water Solubility Insoluble in water
solubility DMF: 30 mg/ml; DMF:PBS(pH7.2) (1:2): 0.33 mg/ml; DMSO: 20 mg/ml; Ethanol: 1 mg/ml
pka 10.49±0.40(Predicted)
form powder to crystal
color White to Almost white
FDA UNII 87T4T8BO2E
ATC code N04BC09

Pharmacokinetic data

Protein binding 92%
Excreted unchanged in urine 71%
Volume of distribution 84(L/kg)
Biological half-life 5-7 / Unchanged

SAFETY

Risk and Safety Statements

Symbol(GHS)  GHS hazard pictogramsGHS hazard pictograms
GHS07,GHS08
Signal word  Warning
Hazard statements  H336-H362-H361
Precautionary statements  P261-P271-P304+P340-P312-P403+P233-P405-P501-P201-P202-P281-P308+P313-P405-P501-P201-P260-P263-P264-P270-P308+P313
Hazard Codes  Xn
Risk Statements  22
HS Code  2934990002

ROTIGOTINE price More Price(28)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
TCI Chemical R0220 Rotigotine 99755-59-6 10MG $150 2024-03-01 Buy
TCI Chemical R0220 Rotigotine 99755-59-6 50MG $557 2024-03-01 Buy
Cayman Chemical 20246 Rotigotine ≥98% 99755-59-6 1mg $32 2024-03-01 Buy
Cayman Chemical 20246 Rotigotine ≥98% 99755-59-6 5mg $78 2024-03-01 Buy
Cayman Chemical 20246 Rotigotine ≥98% 99755-59-6 10mg $109 2024-03-01 Buy
Product number Packaging Price Buy
R0220 10MG $150 Buy
R0220 50MG $557 Buy
20246 1mg $32 Buy
20246 5mg $78 Buy
20246 10mg $109 Buy

ROTIGOTINE Chemical Properties,Uses,Production

Description

While levodopa is still considered the cornerstone of treatment of Parkinson’s disease, many patients begin to experience treatment-related problems, such as a wearing-off phenomenon and the development of dyskinesias as the disease progresses. Continuous dopaminergic stimulation by means of a dopamine agonist has been recognized as being associated with a lower incidence of dyskinesias. Using a selective dopamine agonist as monotherapy in early disease may delay the onset of levodopa therapy, or at a minimum, lower its dose in adjunctive situations to minimize the adverse neurotoxic effects of levodopa. Rotigotine is a nonergolinic dopamine D3/D2/D1 receptor agonist, and it is the first dopamine agonist to be launched as a transdermal patch.

Description

Rotigotine is a non-selective dopamine receptor agonist with pEC50 values of 9.6, 10.4, 8.2, 7.7, and 7.7 for D1, D2, D3, D4, and D5, respectively. It demonstrates a high-affinity for D1, D2, and D3 with lesser affinity for D4 and D5 receptor subtypes. This binding profile is similar to that of apomorphine and pergolide but differentiated from that of pramipexole and ropinirole, which have a more narrow profile of receptor specificity. Each of these agonists demonstrates anti-Parkinsonian effects in animal and clinical models through their ability to directly activate dopamine receptors.

Originator

Aderis (US)

Uses

It is a non-ergot dopamine agonist drug and is indicated for the treatment of Parkinson disease.

Definition

ChEBI: Rotigotine is a member of tetralins.

brand name

Neupro

General Description

Rotigotine, (6S)-6-{propyl[2-(2-thienyl)ethyl]amino}-5,6,7,8-tetrahydro-1-naphthalenol (Neupro),is a nonergoline that is available as a silicone-based, selfadhesivematrix, transdermal system for continuous delivery over a 24-hour period. Approximately 45% of the drug is releasedwithin 24 hours. The terminal half-life of rotigotine is5 to 7 hours after removal of the patch. Rotigotine is 90%bound to plasma proteins. The compound undergoes extensivemetabolism and has low bioavailability by the oralroute. The major metabolites of rotigotine are the glucuronideand sulfate conjugates of rotigotine and sulfateconjugates of N-despropylrotigotine and N-desthienylethylrotigotine. Rotigotine is excreted in the urine (71%) andfeces (11%).Studies using human liver microsomes didnot find any interactions with CYP1A2, CYP2C9,CYP2C19, CYP2D6, and CYP3A4 substrates.Rotigotinetransdermal system contains sodium metabisulfite, and individualssensitive to sulfite could be at risk for allergic reactions.Additionally, somnolence is a common adverse reactionwith individuals on rotigotine, and patients should beclosely monitored during therapy.In transfected Chinesehamster ovary (CHO) cells, rotigotine binds with high affinityat D3 and D2L receptors (variants in the D2 receptor subtypeare caused by insertion of the 29 amino acids into thethird loop to give D2s and D2L).Using rat CHO cells,rotigotine shows over 30-fold selectivity at D3 versus D2 receptors.48 Rotigotine was approved in May 2007 for thetreatment of early-stage PD.

Clinical Use


Treatment of Parkinson’s disease
Restless legs syndrome (RLS)

Synthesis

The synthesis described by the originators at Discovery Therapeutics Inc. (now known as Aderis Pharmaceuticals) is shown in the scheme. The synthesis utilizes the chiral methoxy tetralin 62 as starting precursor which was obtained via chiral crystallization procedure described in a patent literature [34]. Demethylation of tetraline 62 with refluxing 40% HBr solution for several hours provided phenol 63 in 96% yield. Reaction of the amine 63 with 2- thiophenylethyl tosylate 64 in refluxing xylene for 24-32 h in the presence of 0.6 equiv sodium carbonate gave the desired rotigotine (IX) without requiring chromatographic purification. The ratio of sodium carbonate to the amine was critical to achieving good yields (59-84% yield) without requiring extensive purification. Rotigotine was isolated as the HCl salt.

Synthesis_99755-59-6

Drug interactions

Potentially hazardous interactions with other drugs
Antipsychotics: avoid concomitant use (antagonism of effect).
Metoclopramide: avoid concomitant use (antagonism of effect).

Metabolism

Rotigotine is metabolised in the gut wall and liver by N-dealkylation as well as direct and secondary conjugation. Main metabolites are sulfates and glucuronide conjugates of the parent compound as well as N-desalkyl-metabolites, which are biologically inactive. Approximately 71% of the rotigotine dose is excreted in urine and a smaller part of about 23% is excreted in faeces.

125572-93-2
99755-59-6
Synthesis of ROTIGOTINE from (6S)-6-(propyl-(2-thiophen-2-ylethyl)amino)tetralin-1-ol hydrochloride
Global( 245)Suppliers
Supplier Tel Email Country ProdList Advantage
Chengdu Aslee Biopharmaceuticals, Inc.
28-85305008 CHINA 964 58
Xiamen Wonderful Bio Technology Co., Ltd.
+8613043004613 Sara@xmwonderfulbio.com China 305 58
Henan Tianfu Chemical Co.,Ltd.
+86-0371-55170693 +86-19937530512 info@tianfuchem.com China 21688 55
Shanghai Time Chemicals CO., Ltd.
+86-021-57951555 +8617317452075 jack.li@time-chemicals.com China 1807 55
ATK CHEMICAL COMPANY LIMITED
+undefined-21-51877795 ivan@atkchemical.com China 32686 60
Biochempartner
0086-13720134139 candy@biochempartner.com CHINA 967 58
Shenzhen Nexconn Pharmatechs Ltd
+86-755-89396905 +86-15013857715 admin@nexconn.com China 10247 58
Jinan Carbotang Biotech Co.,Ltd.
+8615866703830 figo.gao@foxmail.com China 7154 58
Hubei xin bonus chemical co. LTD
86-13657291602 linda@hubeijusheng.com CHINA 22968 58
Chongqing Chemdad Co., Ltd
+86-023-61398051 +8613650506873 sales@chemdad.com China 39916 58

View Lastest Price from ROTIGOTINE manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
Rotigotine;Rotigotine hydrochloride pictures 2024-01-18 Rotigotine;Rotigotine hydrochloride
99755-59-6
US $15.00 / KG 1KG 99% large quantity Xiamen Wonderful Bio Technology Co., Ltd.
ROTIGOTINE pictures 2019-12-26 ROTIGOTINE
99755-59-6
US $1.00 / KG 1KG 97%-99.9% 100kg Career Henan Chemical Co
  • ROTIGOTINE pictures
  • ROTIGOTINE
    99755-59-6
  • US $1.00 / KG
  • 97%-99.9%
  • Career Henan Chemical Co
()-(S)-5,6,7,8-Tetrahydro-6-(propyl(2-(2-thienyl)ethyl)amino)-1-napht hol (6S)-5,6,7,8-Tetrahydro-6-[propyl[2-(2-thienyl)ethyl]amino]-1-naphthalenol N 0923 SPM 962 (S)-2-[Propyl[2-(2-thienyl)ethyl]amino]tetralin-5-ol [2S,(-)]-N-Propyl-N-[2-(2-thienyl)ethyl]-5-hydroxy-1,2,3,4-tetrahydro-2β-naphthalenamine [S,(-)]-2-[Propyl[2-(2-thienyl)ethyl]amino]tetralin-5-ol S(-)-N-0437 Rotigotine 5,6,7,8-tetrahydro-6-[propyl[2-(2-thienyl)ethyl]amino]-(6S)-1-naphthalenol (?)-(S)-5,6,7,8-Tetrahydro-6-(propyl(2-(2-thienyl)ethyl)amino)-1-naphthol hydrochloride (6S)-6-(Propyl(2-(2-thienyl)ethyl)amino)-5,6,7,8-tetrahydro-1-naphthalenol 1-Naphthalenol, 5,6,7,8-tetrahydro-6-[propyl[2-(2-thienyl)ethyl]aMino]-, (6S)- CS-110 (6S)-6-{propyl[2-(thiophen-2-yl)ethyl]amino}-5,6,7,8-tetrahydronaphthalen-1-ol Rotigotine (Base) ROTIGOTINE USP/EP/BP Rotigotine EP Impurity G Rotigotine (N-0437 RotigotineQ: What is Rotigotine Q: What is the CAS Number of Rotigotine Q: What is the storage condition of Rotigotine Q: What are the applications of Rotigotine 1-a]isoquinolin-4-one 2-morpholino-4H-pyrimido[2 Neupro 14C]-Rotigotine rotigotine impurities 99755-59-6 C19H25NOS Inhibitors Intermediates & Fine Chemicals Pharmaceuticals Sulfur & Selenium Compounds